Dr. Giulia Biancon is an Assistant Professor Adjunct in the Department of Medical Oncology and Hematology at Yale School of Medicine. She holds a PhD from the University of Milan (2019) and is a member of the Halene Lab, focusing on RNA biology and hematologic malignancies. Her research combines high-throughput methodologies to study RNA mechanisms in diseases like myeloid leukemias and splicing factor mutations. Education: PhD in Molecular Biology from the University of Milan (2019). Research Interests: RNA splicing, stress granules in cancer, epitranscriptomics, clonal hematopoiesis, and the interplay between genetic mutations and cellular pathways in blood cancers. Awards: 2024 Eclipse Award, 2022 ASH Abstract Achievement Award, and 2022 RNA Society Best Poster Award. Her work has been published in journals like Cell Reports , Blood , and Molecular Cell . Labs/Teams: Principal member of the Halene Lab and coordinator at the Yale Center for RNA Science and Medicine. Collaborates with institutions like the SeroNet network for immunology studies.
Thibault Mayor is a Professor in the Department of Biochemistry and Molecular Biology and the Michael Smith Laboratories at the University of British Columbia (Vancouver). His research focuses on understanding how cells manage misfolded proteins, with implications for neurodegenerative diseases like Parkinson's and Alzheimer's. He holds academic affiliations with the Centre for High-Throughput Biology (CHiBi) and has been recognized with awards including the UBC Killam Teaching Award (2020). Education: BSc, University of Geneva, Switzerland (1997) PhD, University of Geneva & Max Planck Institute of Biochemistry, Germany (2001) Postdoctoral Fellow, California Institute of Technology (2002) Research Interests: Mayor's lab investigates protein homeostasis, ubiquitin-proteasome system dynamics, and the molecular mechanisms underlying protein aggregation in aging and disease. Projects include proteomic approaches to identify aggregation-prone proteins and develop microbial cell factories for protein production. Grants & Awards: CIHR Project Grant ($730K, 2018) Michael Smith Foundation Career Award (2012) UBC Killam Teaching Award (2020) Labs & Collaborations: The Mayor Lab is part of the Michael Smith Laboratories and collaborates with computational biologists like Jörg Gsponer. They maintain active partnerships in proteomics and systems biology, contributing to initiatives like the BC Proteomics Network.
Professor Jianhua Guo is a faculty member at The University of Queensland (UQ), holding the position of Professor and UQ Amplify Fellow in the Australian Centre for Water and Environmental Biotechnology (ACWEB). He is also the ACWEB Deputy Director - Research. His research focuses on integrating process engineering, environmental microbiology, and biotechnology to develop sustainable solutions for contaminant removal in water and wastewater systems. He is a pioneer in studying the environmental dimension of antimicrobial resistance (AMR), particularly how non-antibiotic pharmaceuticals and chemicals contribute to AMR spread. His groundbreaking work has been featured in over 100 media outlets and has secured over $14M in research funding. He has published over 200 peer-reviewed articles in journals like Nature Microbiology , Water Research , and Environmental Science & Technology . His accolades include the 2013 DECRA and 2017 ARC Future Fellowship. He serves as an editor for Journal of Hazardous Materials and Water Science & Technology . Research Interests Environmental AMR and microbial ecology Methane-based biotechnology and bioconversion Nitrogen cycling microorganisms Bioremediation and biofilm reactors Microplastics and health risks Wastewater treatment innovations Grants & Funding $14M+ in ARC Discovery/Linkage grants and industry partnerships ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (CEA-StAR) Dual-membrane upgrading and anaerobic alkane oxidation projects Awards 2013 DECRA 2017 ARC Future Fellowship Supervision Prof. Guo actively supervises PhD and master’s students in areas like AMR mitigation, methane-based bioreactors, and microbial ecology. Notable supervised projects include studies on antibiotic resistance in wastewater, novel disinfection processes, and microbial oxidation of gaseous alkanes. Labs & Teams He leads research teams within ACWEB and collaborates with the Queensland Alliance for Environmental Health Science. His lab focuses on cutting-edge technologies like membrane biofilm reactors and gas fermentation systems.
Tanja Narancic is an Assistant Professor at the School of Biomolecular and Biomedical Science at University College Dublin (UCD). She is also an academic collaborator at the Bioeconomy Research Centre BiOrbic, where she coordinates multiple research projects among PIs, PostDocs, PhD students, and designs projects proposed by industrial partners. Dr. Narancic earned her PhD in Applied Microbiology from the University of Belgrade, Serbia in 2012, followed by postdoctoral research at the Institute of Molecular Genetics and Genetic Engineering in Belgrade. In 2013, she joined University College Dublin as a Postdoctoral Research Fellow under Prof. Kevin O'Connor, where she investigated microbial metabolic pathways using proteomics, metabolomics, and synthetic biology tools as part of FP7 and H2020 projects. She became a Research Fellow at BiOrbic in 2019 before advancing to her current position as Assistant Professor. Her research focuses on elucidating bacterial metabolism and leveraging synthetic biology tools to exploit bacteria for producing high-value products. Key research areas include: Proteomics, Metabolomics, and Transcriptomics for microbial pathway analysis Metabolic engineering for bioproduction Biocatalysis and enzyme optimization Protein engineering and purification Polyhydroxyalkanoate (PHA) production from waste streams Plastic upcycling and biodegradation technologies Dr. Narancic's publication record demonstrates a strong focus on converting plastic waste into valuable biodegradable materials through innovative biotechnological approaches. Her recent work has centered on developing microbial systems for upcycling polyethylene terephthalate (PET), polyolefins, and other recalcitrant plastics into polyhydroxyalkanoates (PHAs) and other high-value products. She has made significant contributions to understanding the metabolic pathways involved in plastic monomer conversion and has developed engineered strains with enhanced capabilities for plastic upcycling. As a principal investigator, Dr. Narancic leads multiple significant research projects including the Ad Astra Studentship (2023-2028), the UPLIFT project on sustainable plastics for food packaging (2021-2025), and the PROMOFER project (2024-2028) on optimizing PHB production. She also serves as a reviewer for numerous prestigious journals including Enzyme and Microbial Technology, Journal of Applied Microbiology, and Microbial Biotechnology. Her teaching portfolio includes coordination of multiple modules such as Bioprocessing, Metabolism and Disease, and SynBio for Bioeconomy, demonstrating her commitment to educating the next generation of scientists in both fundamental and applied aspects of biomolecular science.
Dan A. Dixon is a Professor and Associate Director of Community Outreach and Engagement at the Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), where his research focuses on post-transcriptional gene regulation mechanisms in cancer pathogenesis. His academic credentials include: Ph.D. from Northwestern University B.A. from Augustana University Dr. Dixon's research centers on RNA-binding proteins (notably HuR and tristetraprolin) and their role in destabilizing oncogenic mRNA networks. His laboratory investigates how dysregulation of these post-transcriptional controllers permits overexpression of tumor-promoting genes involved in proliferation, angiogenesis, and metastasis. Key focus areas include colorectal cancer mechanisms, autophagy regulation via Rab27B, stress granule dynamics in mutant p53 contexts, and extracellular vesicle-mediated tumor microenvironment activation. Analysis of his 2022-2025 publications reveals intensifying work on XPO1 inhibition for colorectal cancer chemoprevention, Rab27B-autophagy axis characterization, and mutant p53 vulnerabilities. His studies consistently employ molecular techniques, mouse models (APC Min/+ ), and translational approaches to identify biomarkers and therapeutic targets. Dr. Dixon maintains active laboratory facilities at WPRCI 947 and 951, directing research that bridges fundamental RNA biology with clinical oncology applications. His leadership in community outreach complements his bench-to-bedside research philosophy.
Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.
Masato Kato serves as Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center since 2020 and concurrently as Team Leader at Japan's National Institutes for Quantum and Radiological Science and Technology. His academic trajectory includes progressive appointments from Assistant Professor (2004-2014) to Associate Professor (2014-2020) at UT Southwestern, with prior postdoctoral training at Harvard Medical School and Nara Institute of Science and Technology. 2020-present: Professor, Department of Biochemistry, UT Southwestern 2020-present: Team Leader, National Institutes for Quantum and Radiological Science and Technology, Japan 2014-2020: Associate Professor, Department of Biochemistry, UT Southwestern 2010-2014: Assistant Professor, Department of Biochemistry and Internal Medicine, UT Southwestern 2004-2010: Assistant Professor, Department of Internal Medicine, UT Southwestern 1999-2004: Postdoctoral Fellow, Ellenberger Lab, Harvard Medical School 1998-1999: Postdoctoral Fellow, Hakoshima Lab, Nara Institute of Science and Technology Dr. Kato's research pioneers the biophysical characterization of protein phase separation, particularly focusing on low-complexity domains (LCDs) in neurodegenerative disease contexts. His work establishes fundamental mechanisms of biomolecular condensate formation, including hydrogel polymerization, liquid-solid transitions, and mutation-induced dysregulation in ALS/FTD. Key contributions demonstrate how C9orf72-encoded poly-dipeptides disrupt nucleocytoplasmic transport and how redox states regulate Ataxin-2 phase behavior, bridging structural biochemistry with pathological mechanisms. Analysis of his 22 publications reveals a cohesive research program centered on LCD-driven phase transitions. The most recent 15 articles (2012-2019) systematically investigate pathological aggregation in neurodegeneration, structural basis of condensate formation, and regulatory mechanisms like phosphorylation and oxidation. This body of work establishes LCDs as central players in both physiological RNA granule assembly and disease-associated solidification, with strong emphasis on C9orf72-related ALS/FTD mechanisms. Dr. Kato maintains active leadership within the McKnight Laboratory at UT Southwestern, where his team employs integrated approaches spanning structural biology, cell biology, and biophysics to dissect phase separation mechanisms. His collaborative network includes prominent neuroscience and biochemistry groups, with co-authorship on key studies in Cell, Science, and PNAS.
Staffan Kjelleberg is a Distinguished University Professor at Nanyang Technological University (NTU), Singapore, and Director of the Singapore National Biofilm Consortium (SNBC) and Singapore Centre for Environmental Life Sciences Engineering (SCELSE). He holds previous positions as Scientia Professor at the University of New South Wales (UNSW), Australia, and has led major research initiatives globally. His academic career spans over four decades, with roles including Head of School at UNSW and Professorships at the University of Gothenburg, Sweden. Education: BSc (Chemistry and Biology, 1975), PhD (Microbiology, 1981), and Docent (Microbiology, 1983) from the University of Gothenburg. He has authored over 384 journal papers with significant citations, reflecting his leadership in microbial biofilm research. Research focuses on microbial biofilms and microbiomes, addressing environmental sustainability, public health, and industrial applications. He employs an interdisciplinary approach to study biofilm community dynamics, matrix properties, and translational technologies for biofilm control. Key contributions include discoveries on quorum sensing inhibitors, biofilm dispersal mechanisms, and eDNA roles in biofilm structure. Honours include Fellowships from the Australian and American Academies of Microbiology, Web of Science Highly Cited Researcher status, and Editor roles for 15 international journals. He leads major programs like the Marine Climate Change Science initiative and has co-directed global research centers such as the Centre for Marine Bio-Innovation. Advising and grants: While specific student names are not listed, his extensive leadership in research programs indicates mentorship of numerous scholars. His work bridges fundamental and applied microbiology, impacting environmental and biomedical fields. Labs/Teams: Directs SCELSE and SNBC, co-founded the Centre for Marine Bio-Innovation, and collaborates internationally on biofilm and microbiome research.
Mark van Loosdrecht is a Full Professor in Environmental Biotechnology at Delft University of Technology (TU Delft), leading the Mark van Loosdrecht Group within the Faculty of Applied Sciences. His research focuses on microbial ecology and innovative wastewater treatment technologies, including biofilm processes, nitrogen/phosphate conversion, and microbial polymer production. He is renowned for developing the Anammox and Nereda technologies, which revolutionize nutrient removal and sludge management in wastewater systems. **Awards & Recognition**: Van Loosdrecht has received prestigious awards such as the Spinoza Award (2014), Stockholm Water Prize (2018), and Lee Kuan Yew Prize (2012). He is a member of the Royal Netherlands Academy of Arts and Sciences and the Dutch and U.S. National Academies of Sciences. **Research Interests**: His work emphasizes sustainable water treatment, resource recovery, and microbial process engineering. Key topics include anaerobic digestion, aerobic granular sludge, and bioremediation strategies for industrial and municipal wastewater. **Publications & Impact**: Over 1,400 peer-reviewed publications and contributions to textbooks like Environmental Biotechnology: Principles and Applications . His research bridges fundamental science with practical applications, addressing global challenges in water management and environmental sustainability. **Affiliations**: He chairs the Environmental Biotechnology section at TU Delft and collaborates globally on projects like the ESDIT initiative, exploring ethics in disruptive technologies.
Hsueh-Chia Chang is the Bayer Professor of Chemical Engineering in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame's College of Engineering. He also holds a concurrent faculty position in the Department of Aerospace and Mechanical Engineering. As Principal Investigator of the Chang Lab, he leads cutting-edge research in microfluidic and nanofluidic technologies for biomedical applications. Prof. Chang received his B.S. in Chemical Engineering from Caltech in 1976, followed by M.S. and Ph.D. degrees in Chemical Engineering from Princeton University in 1977 and 1980, respectively. His academic journey has established him as a leader in the field of microfluidics and biosensing technologies. Chang's research focuses on developing low-cost liquid biopsy nanotechnologies for cancer screening and therapy management. His lab specializes in microfluidic and nanofluidic research coupled with electrokinetics, optics, plasmonics and acoustics for biosensing applications. Key research areas include Electrokinetics & Biosensing, Optics & Plasmonics, Nanoelectrokinetics, and Droplet Microfluidics. The Chang Lab has developed innovative platforms that can isolate and sort tumor cells, exosomes, microvesicles, lipoproteins, and stress granules from blood samples, then lyse these structures to release RNA/protein biomarkers for detection and quantification. His recent publications reveal a strong focus on extracellular vesicle diagnostics, cancer biomarker detection, and point-of-care diagnostic technologies. The research spans multiple disciplines including oncology, cardiology, and neurology, with applications for pancreatic, liver, breast, ovarian, and lung cancers as well as myocardial infarction diagnosis. Fellow of American Institute of Medical and Biological Engineering (2025) Provost Research Achievement Award, Notre Dame (2024) Fellow of the National Academy of Inventors (2020) Lifetime Achievement Award, American Electrophoresis Society (2019) Fellow of the American Physical Society (1997) Presidential Young Investigator Award, NSF (1985) Prof. Chang has advised over 50 PhD students and postdocs who have gone on to prominent positions in academia and industry. His lab has secured significant funding and has commercialized several technologies through startups like Aopia Biosciences, which launched NanoEx at ISEV 2024. The Chang Lab maintains active collaborations with medical researchers for validating their diagnostic platforms against various cancers and cardiac conditions.
David N. Ku is the Lawrence P. Huang Endowed Chair for Engineering Entrepreneurship and Regents' Professor at Georgia Institute of Technology. He holds appointments in the School of Mechanical Engineering (Woodruff School) within the College of Engineering. His research focuses on biofluid mechanics, medical device innovation, and translational technology, with emphasis on thrombosis mechanisms and vascular diseases. Education: M.D. from Emory University (1984); Ph.D. and M.S. from Georgia Tech (1983, 1982); B.A. from Harvard University (1978). Research interests include unsteady fluid dynamics in vascular systems, nanoparticle medical devices for thrombosis prevention, and porous thrombus applications for hemostasis. His work bridges bioengineering with entrepreneurship, teaching product development at the Business School and collaborating with Emory University, Paris Tech-Mines, and ETH Zurich. Key awards include the American Institute for Medical and Biological Engineering Fellowship, DLA Piper Inventor of the Year, and NSF Presidential Young Investigator Award. His research is funded by NIH, NSF, and industry partners. Labs/Teams: Leads a lab using microfluidics and computational mechanics for vascular disease solutions. Collaborates on technologies to address post-partum hemorrhage and traumatic bleeding.
Clifford P. Brangwynne is the June K. Wu '92 Professor of Chemical and Biological Engineering and Bioengineering at Princeton University, serving as Director of the Omenn-Darling Bioengineering Institute. His research bridges biophysics, bioengineering, and cell biology to investigate the physical principles governing intracellular organization through liquid-liquid phase separation. Education Ph.D. in Applied Physics, Harvard University (2007) B.S. in Materials Science and Engineering (minor in Physics), Carnegie Mellon University (2001) Research Focus Brangwynne's lab pioneers the study of membrane-less organelles (biomolecular condensates) formed via phase separation, exploring their roles in nuclear architecture, genome regulation, and disease mechanisms. His work integrates soft matter physics with advanced cell biology to uncover how these condensates form, function, and contribute to pathological protein aggregation in neurodegenerative disorders, while developing synthetic organelle engineering for biomedical applications. Publication Trends His publications consistently demonstrate how liquid phase condensation governs cellular organization across scales—from nuclear genome restructuring to pathological aggregation. The interdisciplinary approach reveals fundamental physical principles while driving technological innovations in organelle engineering and disease modeling. Major Awards Breakthrough Prize for Life Sciences (2023) Raymond and Beverly Sackler International Prize in Biophysics (2023) Tsuneko & Reiji Okazaki Award (2021) Wiley Prize in Biomedical Sciences (2020) Blavatnik National Award in Life Sciences (2020) Human Frontier Science Program Nakasone Award (2020) Michael and Kate Bárány Award, Biophysical Society (2020) HHMI Transformative Technology Award (2019) MacArthur Fellow (2018) HHMI, Simons Foundation, and Bill & Melinda Gates Foundation Faculty Scholar (2016) SCB Gibco Emerging Leader Prize, American Society of Cell Biology (2015) Sloan Research Fellowship (2014) NSF CAREER Award (2013) NIH New Innovator Award (2012) Searle Scholar Award (2012) Helen Hay Whitney Fellow (2008-2010) Advising and Funding He mentors graduate students including Jordy Botello, Yi-Che (Eje) Chang, Yoonji Kim, Claire Weaver, Lennard Wiesner, and Jessica Zhao. Research is supported by HHMI, Simons Foundation, Bill & Melinda Gates Foundation, NIH, NSF, and the Human Frontier Science Program. Laboratory and Collaborations Leading the Soft Living Matter Group, Brangwynne collaborates with theorists including Mikko Haataja (Princeton Mechanical Engineering), Ned Wingreen (Princeton Molecular Biology), and Rohit Pappu (WUSTL), while contributing to the NIH 4D Nucleome Consortium to advance understanding of nuclear organization.
Christopher Lawson is an Assistant Professor in the Department of Chemical Engineering and Applied Chemistry at the University of Toronto, affiliated with the Faculty of Applied Science and Engineering. He serves as Principal Investigator of the Microbiome Engineering Lab and is part of BioZone – the Centre for Applied Bioscience and Bioengineering. His research focuses on engineering anaerobic microbiomes for resource recovery from waste streams using systems biology, synthetic biology, and machine learning approaches. B.A.Sc., M.A.Sc. (University of British Columbia) Ph.D. (University of Wisconsin-Madison) Postdoctoral Training (Berkeley Lab) Lawson's work addresses the challenge of controlling complex microbial interactions in engineered systems to enable scalable biotechnologies for renewable energy, chemicals, and materials. His lab develops high-throughput methods integrating automation and computational tools to optimize microbiome assembly and metabolic fluxes. Recent publications highlight advancements in metabolic modeling , isotope tracing , and systems-level analysis of anaerobic microbiomes, with applications in wastewater treatment , anammox granules , and bioenergy production . His research bridges fundamental microbiology with industrial-scale bioprocess engineering. Scientific Awards ISME/IWA BioCluster Rising Star Award (2022) Jacobs Engineering Group/AEESP Outstanding Doctoral Dissertation Award (2020) Wesley Eckenfelder Graduate Research Award (2019) WEF Canham Graduate Studies Scholarship (2018) NSERC Post-Graduate Scholarship – Doctoral (2014) Lawson actively mentors students and postdocs, emphasizing technical rigor, communication skills, and independence. His lab collaborates within BioZone and with industry partners to advance "team science" principles. Current projects focus on creating engineered microbiomes for commercial-scale waste valorization.
Lande Liu is a Senior Lecturer in Chemical Engineering at the University of Huddersfield's School of Applied Sciences. Previously, he held a Lectureship at the University of Manchester (2010-2014), and earlier worked as an industrial consultant and research fellow at Leeds and Sheffield Universities. His academic journey began with a MEng in Chemical Engineering and a PhD in kinetic theory of aggregation from Sheffield (2004), preceded by a visiting PhD at Twente University (2002). Education: PhD in Chemical Engineering (University of Sheffield, 2004) Visiting PhD (Twente University, 2002) MEng in Chemical Engineering (Tsinghua University, 1999) BSc in Applied Mathematics (Tsinghua University, 1996) Liu's research focuses on multi-scale particle interactions (molecular to granular) using kinetic theory of aggregation, with applications spanning nanotechnology, pharmaceutical engineering, and sustainable chemical processes. His work aligns with UN Sustainable Development Goals for environmental protection and industrial innovation. Recent publications examine particle deposition in turbulent flows, enhanced heat exchanger designs, and nanofluid stabilization techniques. He teaches core chemical engineering topics including transport phenomena, unit operations, and process design. Active in collaborative research, Liu has partnered with institutions across Europe on projects involving spectroscopy, ultrasonics, and dynamic modeling. His technical expertise includes particle size analysis, tomography, and computational simulation of complex systems.
Ruben Portugues is a Professor of Brain Circuit Function and Dysfunction at the Institute of Neuroscience, Technical University of Munich (TUM). He is a full member of the Graduate School of Systemic Neurosciences (GSN), an associate and advisory board member of the Munich Center for Neurosciences (MCN), and leads a research group focused on understanding the neural basis of behavior. His lab uses larval zebrafish as a model organism to investigate sensorimotor control, decision-making, and motor learning through whole-brain imaging and circuit analysis. His research interests lie at the intersection of systems neuroscience and behavior. He investigates how brain circuits process sensory information, integrate it with motor output, and enable adaptive and flexible behavior. Key areas include the function of the cerebellum, heading direction networks, sensorimotor transformations, and the neural mechanisms of decision-making. His lab employs cutting-edge techniques including custom-built microscopes, behavioral assays, and computational analysis. The recent publications and preprints from his lab demonstrate a strong trend in decoding distributed neural circuits underlying navigation and decision-making in zebrafish. There is a clear focus on identifying specific brain regions (e.g., interpeduncular nucleus, cerebellum) and cell types involved in processing visual, motor, and spatial information. The work increasingly emphasizes whole-brain functional imaging and the emergence of cognitive-like representations such as allocentric heading direction. FENS-Kavli Network of Excellence (FKNE) PhD Thesis Prize (awarded to student Luigi Petrucco) Ruben Portugues actively mentors PhD students, including current advisees Luigi Petrucco, Ot Prat, and Shuhong Huang, and has successfully graduated Dr. Elena Dragomir and Dr. Vilim Štih. His lab engages in extensive collaborations, hosts visiting researchers, participates in teaching (e.g., CSHL Imaging Course, Cajal Course), and secures resources for advanced research. The lab is known for building its own microscopes and software, fostering technical innovation. The Portugues Lab operates as a dynamic, interdisciplinary team that combines experimental neuroscience with computational and engineering approaches. They regularly hold retreats, participate in scientific events, and contribute to community initiatives like the Munich Brain Day. The lab is preparing to relocate to the Department of Neurobiology and Behavior at Cornell University, marking a new phase in its research trajectory.
